Ancora Advisors, LLC Harvard Bioscience Inc Transaction History

Ancora Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$5.0 - $6.65 $607,440 - $807,895	-121,488 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$4.2 - $5.95 $115,970 - $164,291	-27,612 Reduced 18.52%	121,488 $650,000
Q1 2018 May 15, 2018	SELL	$3.3 - $5.15 $171,151 - $267,099	-51,864 Reduced 25.81%	149,100 $745,000
Q4 2017 Feb 14, 2018	BUY	$3.08 - $3.8 $29,832 - $36,806	9,686 Added 5.06%	200,964 $663,000
Q3 2017 Nov 14, 2017	BUY	$2.7 - $3.75 $516,450 - $717,292	191,278	191,278 $717,000

30.6M

700

2.1K

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $89.1M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ancora Advisors, LLC with notifications on news.